Article abstract
Nature Chemical Biology 2, 265 - 273 (2006)
Published online: 26 March 2006 | doi:10.1038/nchembio778
Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish
Peter E Bayliss1,6, Kimberly L Bellavance2,6, Geoffrey G Whitehead3, Joshua M Abrams2, Sandrine Aegerter2, Heather S Robbins2, Douglas B Cowan4, Mark T Keating3, Terence O'Reilly5, Jeanette M Wood5, Thomas M Roberts1 & Joanne Chan2
Abstract
We examined the role of angiogenesis and the need for receptor signaling using chemical inhibition of the vascular endothelial growth factor receptor in the adult zebrafish tail fin. Using a small-molecule inhibitor, we were able to exert precise control over blood vessel regeneration. An angiogenic limit to tissue regeneration was determined, as avascular tissue containing skin, pigment, neuronal axons and bone precursors could regenerate up to about 1 mm. This indicates that tissues can regenerate without direct interaction with endothelial cells and at a distance from blood supply. We also investigated whether the effects of chemical inhibition could be enhanced in zebrafish vascular mutants. We found that adult zebrafish, heterozygous for a mutation in the critical receptor effector phospholipase C
1, show a greater sensitivity to chemical inhibition. This study illustrates the utility of the adult zebrafish as a new model system for receptor signaling and chemical biology.
- Department of Cancer Biology, Dana-Farber Cancer Institute and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Vascular Biology Program, Children's Hospital and the Department of Surgery, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Department of Cardiology, Children's Hospital, Howard Hughes Medical Institute and the Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Department of Anesthesia, Harvard Medical School and Children's Hospital, Boston, Massachusetts 02115, USA.
- Oncology Research, Novartis Pharma AG, CH-4002 Basel, Switzerland.
- These authors contributed equally to this work.
Correspondence to: Joanne Chan2 e-mail: joanne.chan@childrens.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Fishing and frogging for anti-angiogenic drugsNature Chemical Biology News and Views (01 May 2006)
Heads or tails: can Wnt tell which one is up?Nature Cell Biology News and Views (01 Feb 2008)
See all 4 matches for News And ViewsRESEARCH
Patterning the zebrafish axial skeleton requires early chordin functionNature Genetics Letter (01 Dec 1999)
See all 35 matches for Research